Laparotomy for post chemotherapy residue in ovarian germ cell tumors

Journal of Postgraduate Medicine

Volumn 52, Issue 4, 2006, Pages 262-265

  Mathew, G K ^a   Singh, S S ^a   Swaminathan, R G ^a   Tenali, S G ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Laparotomy; Ovarian germ cell tumor; Post chemotherapy residue

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FIBROSIS; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY TUMOR; TERATOMA; TUMOR NECROSIS;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROTOMY; NEOPLASM, RESIDUAL; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33845246368     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Williams SD. Ovarian germ cell tumors: An update. Semin Oncol 1998;25:407-13.
2. Abu-Rustum, Aghajanian C. Management of germ cell tumors of the ovary. Semin Oncol 1998;2:235-42.
3. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 1994;12:701-6.
4. Loehrer PJ Sr, Hui S, Clark S, Seal M, Einhorn LH, Williams SD, et al. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: A clinicopathological correlation. J Urol 1986;135:1183-9.
5. rd, Liao SY. Second look laparotomy in ovarian germ cell tumours: The gynecologic oncology group experience. Gynaec Oncol 1994;52:287-91.
6. Gershenson DM, Copeland LJ, del Junco G, Edwards CL, Wharton JT, Rutledge FN. Second look laparotomy in the management of malignant germ cell tumors of the ovary. Obstet Gynecol 1986;67:789-93.
7. Culine S, Lhomme C, Michel G, Leclere J, Duvillard P, Droz JP. Is there a role for second look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at the Institut Gustave Roussy. J Surg Oncol 1996;62:40-5.
8. Bafna UD, Umadevi K, Kumaran C, Nagarathna DS, Shashikala P, Tanseem R. Germ cell tumors of the ovary: Is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors? Int J Gynecol Cancer 2001;11:300-4.
9. Pipit CH Jr, Cain JM, Hakes TB, Pierce VK, Lewis JL Jr. Primary chemotherapy and the role of second-look laparotomy in nondysgerminomatous germ cell malignancies of the ovary. Gynaec Oncol 1988;31:268-75.
10. Slayton RE. Management of germ cell and stromal tumours of the ovary. Semin Oncol 1984;11:299-313.
11. Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L. Cisplatin, vinblastin and bleomycin in advanced and recurrent ovarian germ cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 1989;111:22-7.